Literature DB >> 23024840

Endovascular treatment of extracranial vertebral artery stenosis.

Burak Kocak1, Bora Korkmazer, Civan Islak, Naci Kocer, Osman Kizilkilic.   

Abstract

Percutaneous angioplasty and stenting for the treatment of extracranial vertebral artery (VA) stenosis seems a safe, effective and useful technique for resolving symptoms and improving blood flow to the posterior circulation, with a low complication rate and good long-term results. In patients with severe tortuosity of the vessel, stent placement is a real challenge. The new coronary balloon-expandable stents may be preferred. A large variability of restenosis rates has been reported. Drug-eluting stents may be the solution. After a comprehensive review of the literature, it can be concluded that percutaneous angioplasty and stenting of extracranial VA stenosis is technically feasible, but there is insufficient evidence from randomized trials to demonstrate that endovascular management is superior to best medical management.

Entities:  

Keywords:  Angioplasty; Endovascular treatment; Stent; Vertebral artery stenosis

Year:  2012        PMID: 23024840      PMCID: PMC3460226          DOI: 10.4329/wjr.v4.i9.391

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  86 in total

1.  Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation.

Authors:  Rishi Gupta; Firas Al-Ali; Ajith J Thomas; Michael B Horowitz; Thomas Barrow; Nirav A Vora; Ken Uchino; Maxim D Hammer; Lawerence R Wechsler; Tudor G Jovin
Journal:  Stroke       Date:  2006-09-07       Impact factor: 7.914

2.  Vertebral artery origin stenting with buddy wire technique in tortuous subclavian artery.

Authors:  Osman Kizilkilic
Journal:  Eur J Radiol       Date:  2006-09-22       Impact factor: 3.528

Review 3.  Endovascular treatment of vertebral artery-origin and innominate/subclavian disease: indications and technique.

Authors:  Guilherme Dabus; Christopher J Moran; Colin P Derdeyn; Dewitte T Cross
Journal:  Neuroimaging Clin N Am       Date:  2007-08       Impact factor: 2.264

4.  The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin.

Authors:  Andrew L Frelinger; Joseph A Jakubowski; Youfu Li; Marc R Barnard; Marsha L Fox; Matthew D Linden; Atsuhiro Sugidachi; Kenneth J Winters; Mark I Furman; Alan D Michelson
Journal:  Thromb Haemost       Date:  2007-07       Impact factor: 5.249

5.  Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.

Authors:  Robert J Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Ralph L Sacco; Lee H Schwamm
Journal:  Stroke       Date:  2008-03-05       Impact factor: 7.914

6.  Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study.

Authors:  Dominick J Angiolillo; Steven B Shoemaker; Bhaloo Desai; Hang Yuan; Ronald K Charlton; Esther Bernardo; Martin M Zenni; Luis A Guzman; Theodore A Bass; Marco A Costa
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

7.  Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures.

Authors:  A A Dawkins; A L Evans; J Wattam; C A J Romanowski; D J A Connolly; T J Hodgson; S C Coley
Journal:  Neuroradiology       Date:  2007-06-27       Impact factor: 2.804

8.  Stenting of vertebral artery origin atherosclerosis in high-risk patients: bare or coated? A single-center consecutive case series.

Authors:  Paul T Akins; Charles W Kerber; Ramin S Pakbaz
Journal:  J Invasive Cardiol       Date:  2008-01       Impact factor: 2.022

Review 9.  Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Authors:  Dominick J Angiolillo; Antonio Fernandez-Ortiz; Esther Bernardo; Fernando Alfonso; Carlos Macaya; Theodore A Bass; Marco A Costa
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

10.  Long-term outcome after angioplasty and stenting for symptomatic vertebral artery stenosis compared with medical treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial.

Authors:  Lucy J Coward; Dominick J H McCabe; Joerg Ederle; Roland L Featherstone; Andrew Clifton; Martin M Brown
Journal:  Stroke       Date:  2007-03-29       Impact factor: 7.914

View more
  9 in total

1.  Contrast-less stent placement for vertebral artery origin stenosis.

Authors:  Shinzo Ota; Yoshinobu Sekihara; Takahiro Himeno; Yasue Tanaka; Tatsuya Ohtonari
Journal:  Interv Neuroradiol       Date:  2016-11-30       Impact factor: 1.610

2.  The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment.

Authors:  Yong-Juan Lin; Jing-Wei Li; Mei-Juan Zhang; Lai Qian; Wen-Jie Yang; Chun-Lei Zhang; Yuan Shao; Yang Zhang; Yu-Jie Huang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2013-12-12       Impact factor: 5.243

3.  Seven years' follow-up of comparative study between stenting and medication for treatment of symptomatic vertebrobasilar artery stenosis.

Authors:  Jun Wang; Changyang Zhong; Yan Zhang; Yingnan Wei; Huili Liu; Chunli Wu; Yongxing Yan
Journal:  Interv Neuroradiol       Date:  2017-10-23       Impact factor: 1.610

4.  Validation and comparison of drug eluting stent to bare metal stent for restenosis rates following vertebral artery ostium stenting: A single-center real-world study.

Authors:  Long Li; Xu Wang; Bin Yang; Yabing Wang; Peng Gao; Yanfei Chen; Fengshui Zhu; Yan Ma; Haitao Chi; Xiao Zhang; Xuesong Bai; Yao Feng; Adam A Dmytriw; Tao Hong; Yang Hua; Liqun Jiao; Feng Ling
Journal:  Interv Neuroradiol       Date:  2020-08-16       Impact factor: 1.610

5.  Angioplasty and stenting for severe vertebral artery orifice stenosis: effects on cerebellar function remodeling verified by blood oxygen level-dependent functional magnetic resonance imaging.

Authors:  Bo Liu; Zhiwei Li; Peng Xie
Journal:  Neural Regen Res       Date:  2014-12-01       Impact factor: 5.135

6.  Comparison of hemodynamic changes and prognosis between stenting and standardized medical treatment in patients with symptomatic moderate to severe vertebral artery origin stenosis.

Authors:  Jia-Xin Shao; Yun-Ao Ling; Hua-Ping Du; Guo-Jie Zhai; Yuan Xu; Yong-Jun Cao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

7.  Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting.

Authors:  Damian R Maciejewski; Piotr Pieniazek; Lukasz Tekieli; Piotr Paluszek; Tadeusz Przewlocki; Tomasz Tomaszewski; Roman Machnik; Mariusz Trystula; Jacek Legutko; Anna Kablak-Ziembicka
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-09-18       Impact factor: 1.426

Review 8.  Vertebral Artery Stenosis: A Narrative Review.

Authors:  Venkata Sathya Burle; Amelia Panjwani; Kesava Mandalaneni; Sunitha Kollu; Vasavi Rakesh Gorantla
Journal:  Cureus       Date:  2022-08-16

9.  128-slice acceletated-pitch dual energy CT angiography of the head and neck: comparison of different low contrast medium volumes.

Authors:  Yu Chen; Huadan Xue; Zheng-yu Jin; Jie Zhang; Hao Sun; Xuan Wang; Zhu-hua Zhang; Da-ming Zhang; Guang-ming Lu; Zhao-qi Zhang; U Joseph Schoepf; Andreas M Bucher; Christopher D Wolla; Yun Wang
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.